ALLEGAN, Mich., June 9, 2023 /PRNewswire/ — Padagis today announced the launch of Tazarotene Gel (generic to Tazorac® Gel) and Methylphenidate Transdermal System (authorized generic to Daytrana®). Tazorac® Gel 0.05% and 0.1% are indicated for the topical treatment of patients with plaque…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.